DNA Biomed Solns (DNA) — Free Cash Flow Generation Index

Latest as of December 2022: 1.00x

DNA Biomed Solns (DNA) has a Free Cash Flow Generation Index of 1.00x as of December 2022. Free cash flow of ILA394.50K represents 1% of operating cash flow (ILA394.50K). Check DNA goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

FCF Generation Index

1.00x

Free Cash Flow / Operating CF

Free Cash Flow

ILA394.50K

ILA

Operating Cash Flow

ILA394.50K

ILA

Capital Expenditures

ILA0.00

ILA

DNA Biomed Solns Free Cash Flow Generation Index (2024–2024)

Historical FCF Generation Index trend for DNA Biomed Solns across 1 annual periods. For the full cash flow conversion analysis, see cash flow conversion of DNA Biomed Solns.

Annual Free Cash Flow Generation for DNA Biomed Solns (2024–2024)

Year-by-year Free Cash Flow Generation Index for DNA Biomed Solns. Check how aggressively does DNA Biomed Solns reinvest cash to assess the company's total reinvestment commitment from operating cash flow.

Year	FCG Index	Free Cash Flow (ILA)	Operating CF	Capital Expenditures	YoY Change
2024	1.00x	ILA1.61 Million	ILA1.61 Million	ILA0.00	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).